We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Unveils Plan to Reorganize CDER’s Drug Reviews
FDA Unveils Plan to Reorganize CDER’s Drug Reviews
CDER Director Janet Woodcock outlined an ambitious plan to reorganize the center’s drug reviews by centralizing project management under the Office of New Drugs.